BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-210@pharmaconomics
DTSTAMP:20260707T034205Z
DTSTART;VALUE=DATE:20260430
DTEND;VALUE=DATE:20260501
SUMMARY:AXSM PDUFA — AXS-05
DESCRIPTION:The FDA's approval decision on AXS-05 for Alzheimer’s disease agitation is due Apr 30\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1579428/000119312526062421/axsm-ex99_1.htm\n\nTrack it: https://www.pharmaconomics.com/e/210
URL:https://www.pharmaconomics.com/e/210
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:AXSM catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR